Challenging the boundaries of anemia management: a balanced approach to i.v. iron and EPO therapy

被引：9
作者：
Coyne, D [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63110 USA
来源：
KIDNEY INTERNATIONAL | 2006年 / 69卷
关键词：
D O I：
10.1038/sj.ki.5000402
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1 / S3
页数：3
相关论文
共 25 条
[1]   Effect of recombinant human erythropoietin on inflammatory status in dialysis patients [J].
Aguilera, A ;
Selgas, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 :46-53
[2]   Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjects [J].
Annuk, M ;
Linde, T ;
Lind, L ;
Fellström, B .
NEPHRON CLINICAL PRACTICE, 2006, 102 (01) :C30-C34
[3]  
[Anonymous], 2001, Am J Kidney Dis, V37, pS182
[4]   HFE genotype in patients with hemochromatosis and other liver diseases [J].
Bacon, BR ;
Olynyk, JK ;
Brunt, EM ;
Britton, RS ;
Wolff, RK .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (12) :953-962
[5]  
Besarab A, 1999, J AM SOC NEPHROL, V10, P2029
[6]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[7]  
BEUTLER E, 2003, HEMATOLOGY AM SOC HE, V16, P40
[8]  
Chang CH, 2002, CLIN NEPHROL, V57, P136
[9]   Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Berkoben, M ;
Heyka, R ;
Kaufman, A ;
Lewis, J ;
Rocco, M ;
Toto, R ;
Windus, D ;
Ornt, D ;
Levey, AS .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2380-2389
[10]  
Di Benedetto A, 2005, J NEPHROL, V18, P592
123